Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Comparison Group”

2,825 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 2,825 results

Large-scale testing (Phase 3)Study completedNCT00412100
What this trial is testing

Oxycodone-naloxone Prolonged Release Tablets in Relieving Opioid-related Constipation

Who this might be right for
Pain
Mundipharma Research GmbH & Co KG
Not applicableStudy completedNCT04159636
What this trial is testing

Pulmonary Aspiration in Elderly Patients

Who this might be right for
Anesthesia
Kangbuk Samsung Hospital 58
Large-scale testing (Phase 3)Study completedNCT02558400
What this trial is testing

Double-masked Study of PG324 Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension

Who this might be right for
Open-angle GlaucomaOcular Hypertension
Aerie Pharmaceuticals 718
Testing effectiveness (Phase 2)Study completedNCT06124807
What this trial is testing

LY3305677 Compared With Placebo in Adult Participants With Obesity or Overweight

Who this might be right for
ObesityOverweight and Obesity
Eli Lilly and Company 179
Not applicableStudy completedNCT02138071
What this trial is testing

Psychological Variables in Physiotherapy Treatment of Low Back Pain: A Comparison of Group and Individual Treatment

Who this might be right for
Low Back Pain
Bait Balev Hospital 180
Large-scale testing (Phase 3)Study completedNCT00611026
What this trial is testing

Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine Extended Release(ER)in Patients With Overactive Bladder.

Who this might be right for
Overactive Bladder
Pfizer 2,417
Not applicableNot Yet RecruitingNCT07676708
What this trial is testing

Patterns of Aortic Isthmus Doppler in Early Fetal Growth Restriction , and the Changes in Aortic Isthmus Doppler Parameters With Every Changes of Other Early Iugr Parameters Like EFW, Uterine Artery Doppler, Cerebroplacental Ratio and Ductus Venosus Doppler in Comparison With Normal Group .

Who this might be right for
Fetal Growth RestrictionPlacental InsufficiencyAortic Isthmus Doppler+1 more
Assiut University 100
Not applicableUnknownNCT03608176
What this trial is testing

Evaluation of the Plant-based Approaches to Stop Obesity Diet for the Treatment of Overweight and Obesity

Who this might be right for
Overweight and Obesity
Universidad de Sonora 36
Not applicableUnknownNCT05272215
What this trial is testing

BODY-Q Longitudinal Result Study and Comparison With Normative Scores

Who this might be right for
Weight LossExcess Skin
Odense University Hospital 20,000
Not applicableUnknownNCT06396468
What this trial is testing

Sevoflurane and Intravenous Anesthesia in Hypospadias Repair

Who this might be right for
Emergence DeliriumIntravenous AnesthesiaSevoflurane
Benha University 90
Large-scale testing (Phase 3)Study completedNCT06497491
What this trial is testing

An Efficacy and Safety Study of GNR-086 (Canakinumab Biosimilar) and Ilaris® in Patients With Adult-onset Still's Disease

Who this might be right for
Still's Disease Adult Onset
AO GENERIUM 118
Post-approval studies (Phase 4)Study completedNCT00631917
What this trial is testing

A Study Evaluating the Gastrointestinal (GI) Safety and Tolerability of Aliskiren Compared to Ramipril in Essential Hypertension

Who this might be right for
Hypertension
Novartis 774
Testing effectiveness (Phase 2)Ended earlyNCT00808210
What this trial is testing

Evaluate Ocrelizumab in Combination With Methotrexate Compared With Infliximab Plus Methotrexate in Patients With Active Rheumatoid Arthritis Currently Responding Inadequately to Etanercept or Adalimumab

Who this might be right for
Rheumatoid Arthritis
Genentech, Inc. 28
Testing effectiveness (Phase 2)Study completedNCT00275197
What this trial is testing

A Research Study to Compare the Treatments of a Combination of Elzasonan With Zoloft, to Zoloft Alone, or Placebo in People With Major Depressive Disorder (MDD)

Who this might be right for
Depressive Disorder, Major
Pfizer 262
Post-approval studies (Phase 4)Looking for participantsNCT07791797
What this trial is testing

Supplementation Absorption Comparison

Who this might be right for
Healthy Volunteer
RDC Clinical Pty Ltd 160
Not applicableStudy completedNCT01690897
What this trial is testing

Randomized Comparison of Mindfulness Versus Group Support for Treatment of Low Sexual Desire in Women

Who this might be right for
Low Female Sexual Desire
University of British Columbia 149
Testing effectiveness (Phase 2)Study completedNCT01193218
What this trial is testing

Empagliflozin (BI 10773) Dose Finder Study in Japanese Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 547
Large-scale testing (Phase 3)Not Yet RecruitingNCT07579910
What this trial is testing

Intracerebroventricular Tralesinidase Alfa in Participants With MPS IIIB (Sanfilippo Syndrome Type B)

Who this might be right for
MPS IIIB
Spruce Biosciences 14
Post-approval studies (Phase 4)Study completedNCT03055494
What this trial is testing

Study to Explore the Effect of Secukinumab, Compared to Placebo, on Fat Tissue and Skin in Plaque Psoriasis Patients

Who this might be right for
Plaque Psoriasis
Novartis Pharmaceuticals 102
Early research (Phase 1)Looking for participantsNCT07358156
What this trial is testing

Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.

Who this might be right for
Atopic Dermatitis
Chong Kun Dang Pharmaceutical 519
Next Page